サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654659

新生児用人工呼吸器の世界市場：2025年～2033年

Global Neonatal Ventilators Market - 2025-2033

出版日
ページ情報
英文 205 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
新生児用人工呼吸器の世界市場：2025年～2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 205 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

新生児用人工呼吸器の世界市場は、2024年に4億3,906万米ドルに達し、2033年までには7億854万米ドルに達すると予測され、予測期間中の2025年から2033年のCAGRは5.4%で成長する見込みです。

新生児用人工呼吸器は、新生児、特に早産児や呼吸障害を持つ新生児に呼吸サポートを提供するために設計された医療機器です。酸素の供給と二酸化炭素の除去によって呼吸プロセスを制御し、十分なガス交換を確保します。これらの人工呼吸器は、新生児特有の生理学的ニーズを満たすように調整されており、肺損傷を最小限に抑え、呼吸サポートを最大化するために、圧力、容積、流量を正確に制御します。呼吸窮迫症候群や無呼吸などの状態を管理するために、新生児集中治療室で一般的に使用されています。

市場力学：

促進要因と抑制要因

早産患者の増加

世界の新生児用人工呼吸器市場は、呼吸窮迫症候群や未熟児無呼吸症候群などの合併症を引き起こすことが多い早産児の増加により成長しています。全生児出生数の10％を占める早産児は、救命のために特殊な人工呼吸器を必要とします。新生児の健康に対する意識の高まりと死亡率減少の必要性は、早産児の増加する負担を管理する上での新生児用人工呼吸器の重要性を強調しています。

例えば、欧州新生児ケア財団（EFCNI）によると、世界では年間約1,340万人の赤ちゃんが早産で生まれており、合併症は世界の5歳未満児死亡の主な原因となっています。早産児の多くは、学習障害や視覚・聴覚障害など、生涯にわたる障害を抱えています。早産率は184カ国で5％から18％です。生存率は極めて低く、低所得層では32週以下で出生した赤ちゃんの半数が、基本的なケアが受けられないために死亡しています。欧州では、早産は新生児死亡の2大原因の1つであり、幼児期以降の死亡原因の半分以上を占めています。

人工呼吸器に関連する高コスト

新生児用人工呼吸器の世界市場は、多額の投資とメンテナンスを必要とする人工呼吸器の高コストが足かせとなっており、中低所得国のヘルスケア施設にとっては厳しいものとなっています。このような経済的負担は、資源に乏しい環境におけるこれらの機器の採用を制限し、市場成長の妨げにもなっています。例えば、新生児用人工呼吸器のおおよそのコストは米国で15,000米ドルから2万米ドル程度であり、これが予測期間中の市場を阻害する主な要因の1つとなっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 早産の増加
    • 抑制要因
      • 人工呼吸器にかかる高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 製品タイプ別

  • 侵襲的人工呼吸器
  • 非侵襲性人工呼吸器

第7章 モビリティ別

  • 集中治療システム
  • ポータブルシステム

第8章 技術別

  • 人工呼吸器
  • 高周波人工呼吸器
  • 容積制御人工呼吸器
  • ハイブリッド人工呼吸器

第9章 モード別

  • 圧力モード換気
  • 複合モード換気
  • ボリュームモード換気
  • その他のモード

第10章 エンドユーザー別

  • 病院
  • 新生児クリニック
  • 外来手術センター

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第13章 企業プロファイル

  • Air Liquide
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 過去および予測の製品販売
      • 製品販売量
    • 財務概要
      • 会社の収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • Breas Medical
  • Dragerwerk AG & Co. KGaA
  • GE Healthcare
  • HAMILTON MEDICAL
  • Getinge Group
  • Medtronic plc
  • ICU Medical
  • Vyaire Medical
  • ResMed
  • ACUTRONIC Medical Systems AG
    • パイプライン製品の説明
    • 製品の主要業績評価指標（KPI）
    • 主な活動
    • 市場参入のタイムライン
    • 製品普及率
    • 売上予測と予測
  • Vyaire Medical, Inc
  • Dragerwerk AG & Co. KGaA
  • 各市場参入企業に対しても同様のデータが提供されます。

第14章 付録

目次
Product Code: MD7483

The Global Neonatal Ventilators Market reached US$ 439.06 million in 2024 and is expected to reach US$ 708.54 million by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033.

Neonatal ventilators are medical devices designed to provide respiratory support to newborns, especially those with preterm infants or respiratory disorders. They control the breathing process by delivering oxygen and removing carbon dioxide, ensuring adequate gas exchange. These ventilators are tailored to meet newborns' unique physiological needs, offering precise pressure, volume, and flow controls to minimize lung injury and maximize respiratory support. They are commonly used in neonatal intensive care units to manage conditions like respiratory distress syndrome and apnea.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Preterm Births

The global neonatal ventilators market is growing due to the rise in preterm births, which often result in complications like respiratory distress syndrome and apnea of prematurity. Preterm infants, who account for 10% of all live births, require specialized ventilators for life-saving support. The increasing awareness of neonatal health and the need to reduce mortality rates underscore the importance of neonatal ventilators in managing the growing burden of preterm births.

For instance, according to The European Foundation for the Care of Newborn Infants (EFCNI), Around 13.4 million babies are born preterm annually globally, with complications being the main cause of global under-5 deaths. Many survivors face lifetime disabilities, including learning disabilities and visual and hearing problems. Preterm birth rates range from 5% to 18% in 184 countries. Survival rates are stark, with low-income settings experiencing half of babies born at or below 32 weeks dying due to lack of basic care. In Europe, preterm birth is one of the two leading causes of neonatal mortality and accounts for over half of all deaths in later childhood.

High Cost associated with the Ventilators

The global market for neonatal ventilators is hindered by their high cost, which requires substantial investment and maintenance, which can be challenging for healthcare facilities in low- and middle-income countries. This financial burden also limits the adoption of these devices in resource-constrained settings, hindering market growth. For instance, the approx cost of neonatal ventilators costs around US$ 15000-US$ 20,000 which is one of the major factor that hinders the market during the forecast period.

Segment Analysis

The global Neonatal Ventilators Market is segmented based on Product Type, Mobility, Technology, Mode, End User and Region.

Product Type:

Invasive Ventilators segment is expected to dominate the Neonatal Ventilators market share

The invasive ventilators segment holds a major portion of the Neonatal Ventilators market share and is expected to continue to hold a significant portion of the Neonatal Ventilators market share during the forecast period.

Invasive ventilators are essential in the global neonatal ventilators market, particularly for newborns with severe respiratory conditions. They insert a tube into the infant's airway, typically through the trachea, to ensure a secure and controlled airway for effective ventilation. They are used in critical situations like respiratory distress syndrome, where non-invasive methods may not be sufficient. Invasive ventilators provide precise control over air pressure, volume, and oxygen delivery, essential for managing neonates' delicate lungs. The demand for these ventilators continues to grow in neonatal intensive care units worldwide.

For instance, in November 2024, Inspiration Healthcare Group has launched the SLE1500, a compact respiratory support system designed for the smallest and most vulnerable neonatal patients. This invasive ventilation mode is designed to protect their fragile lungs and is part of their specialist neonatal ventilator range.

End Users:-

Hospitals segment is the fastest-growing segment in Neonatal Ventilators market share

The hospitals segment is the fastest-growing segment in the Neonatal Ventilators market share and is expected to hold the market share over the forecast period.

The global neonatal ventilators market is largely driven by hospitals, particularly neonatal intensive care units (NICUs), which provide specialized care for newborns with critical health issues. The adoption of advanced ventilator technologies, coupled with a focus on improving neonatal outcomes and reducing mortality rates, drives market demand. The increasing number of NICUs and improvements in hospital infrastructure also contribute to market growth.

For instance, in January 2025, Gleneagles Hospitals in Parel, Mumbai has expanded its obstetrics services and introduced a new Neonatal Intensive Care Unit (NICU) to improve maternal and newborn healthcare. The NICU, equipped with four beds, is designed for neonates up to 30 days old, particularly those born prematurely or with critical conditions. It features advanced ventilators, warmers, and neurodevelopment assessment tools to manage respiratory distress, infections, and growth concerns. A team of trained pediatricians and nurses provides 24x7 monitoring and expert care.

Geographical Analysis

North America is expected to hold a significant position in the Neonatal Ventilators market share

North America holds a substantial position in the Neonatal Ventilators market and is expected to hold most of the market share due to rising preterm births, advancements in care technologies, and high healthcare expenditure. The region's well-established healthcare infrastructure and government initiatives for neonatal health, along with increased awareness and adoption of innovative ventilator technologies by leading facilities, support market expansion.

For instance, according to March of Dimes' 2024 Report Card reveals a high US preterm birth rate of 10.4%, with significant disparities among racial and ethnic groups. The report highlights the need for improved maternal and infant health outcomes and emphasizes the urgent need to prioritize the health of mothers and babies.

Europe is growing at the fastest pace in the Neonatal Ventilators market

Europe holds the fastest pace in the Neonatal Ventilators market and is expected to hold most of the market share due to government initiatives, product launches, strong healthcare policies, investment in medical device research, and key market players. The growing awareness of advanced ventilatory support and a focus on reducing neonatal mortality rates contributes to market growth in Europe.

For instance, in December 2024, Europlaz, a UK-based company, has developed a medical innovation that could improve neonatal care and save lives. The Chelmsford-based company believes that ventilator manufacturers should consider switching to this neonatal flow sensor to save lives, reduce NHS costs, and avoid costly litigation. The innovation has been developed for years.

Competitive Landscape

The major global players in the neonatal ventilators market include Air Liquide, Breas Medical, Dragerwerk AG & Co. KGaA, GE Healthcare, HAMILTON MEDICAL, Getinge Group, Medtronic plc, ICU Medical, Vyaire Medical, ResMed and among others.

Key Developments

  • In September 2024, The Fritz Stephan 'STEPHANIE' Neonatal & Infant Ventilator, designed to meet neonatal and paediatric requirements, have been officially launched at the Association of Anaesthetists Annual Congress. The new STEPHANIE, bringing 50 years of expertise, offers unique performance and a modular design structure that simplifies everyday hospital life and offers added flexibility. It is fully equipped to prepare for the ventilation of newborns and preterm infants, showcasing how clinical experience and technical expertise can create outstanding products.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Neonatal Ventilators market report delivers a detailed analysis with 78 key tables, more than 72 visually impactful figures, and 205 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Mobility & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Mobility
  • 3.3. Snippet by Technology
  • 3.4. Snippet by Mode
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Preterm Births
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost associated with the Ventilators
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Invasive Ventilators*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Invasive Ventilators

7. By Mobility

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 7.1.2. Market Attractiveness Index, By Mobility
  • 7.2. Intensive Care System*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Portable System

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Mechanical ventilators*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. High frequency ventilators
  • 8.4. Volume targeted ventilators
  • 8.5. Hybrid ventilators

9. By Mode

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 9.1.2. Market Attractiveness Index, By Mode
  • 9.2. Pressure Mode Ventilation*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Combined Mode Ventilation
  • 9.4. Volume Mode Ventilation
  • 9.5. Other Modes

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Neonatal Clinics
  • 10.4. Ambulatory Surgical Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

Key Market Players

  • 13.1. Air Liquide*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Breas Medical
  • 13.3. Dragerwerk AG & Co. KGaA
  • 13.4. GE Healthcare
  • 13.5. HAMILTON MEDICAL
  • 13.6. Getinge Group
  • 13.7. Medtronic plc
  • 13.8. ICU Medical
  • 13.9. Vyaire Medical
  • 13.10. ResMed
  • Similar data will be provided for each market player.

Emerging Market Players

  • 13.11. ACUTRONIC Medical Systems AG*
    • 13.11.1. Pipeline Products Description
    • 13.11.2. Product Key Performance Indicators (KPIs)
    • 13.11.3. Key Activities
    • 13.11.4. Market Entry Timelines
    • 13.11.5. Product Penetration Rate
    • 13.11.6. Sales Estimation and Projections
  • 13.12. Vyaire Medical, Inc
  • 13.13. Dragerwerk AG & Co. KGaA
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1 About Us and Services
  • 14.2 Contact Us